Media release

DKSH Radiates Compassion by Extending Support to a Cancer Hospital in India

Back
DKSH Radiates Compassion by Extending Support to a Cancer Hospital in India

DKSH India has donated to Tata Memorial Hospital in Mumbai to assist in procuring over 450 central line access catheters (4fr Groshong) PICC kits, enhancing cancer patient care for those in need.

Mumbai, India, May 27, 2024 – DKSH, a leading distributor of specialty chemicals and ingredients, extended its support to Tata Memorial Hospital in Mumbai with a donation. DKSH’s contribution to Tata Memorial Hospital allows to procure central line access catheters and therefore serves as a tangible beacon of hope for cancer patients seeking treatment, representing a source of encouragement amidst their challenging journeys.

This donation is in line with DKSH’s sustainability initiatives, through which the company creates opportunities for development and improvement across society. DKSH is deeply rooted in the communities it serves and strives to create positive impacts beyond business activities. A strong commitment to the local communities that the company is active in has always been an integral part of its business. 

Tata Memorial Hospital conducts over 150,000 chemotherapy sessions annually in its outpatient ward. However, patients in need of continuous or prolonged chemotherapy cannot receive it in this setting. Instead, they undergo central venous line access, involving the insertion of a catheter into their central venous system, typically the superior vena cava, through which chemotherapy is administered. This allows patients to return home while receiving ongoing chemotherapy, reducing hospital stays and the risk of complications such as leakage or infection. The standard catheter used for this purpose is the 4fr Groshong, the one Tata Memorial Hospital can procure with DKSH’s donation. On average, around 250 patients require this catheter every month.

Dr C S Pramesh, Director, Tata Memorial Hospital, commented: “On behalf of our patients, we are deeply grateful to DKSH for their generous support in providing central line venous access catheters. This contribution will greatly enhance access to chemotherapy, offering greater convenience and comfort to our patients.”
 
Vishal Jawale, Managing Director, DKSH India, stated: “We are very pleased to serve this noble cause. This project aimed at enhancing lives aligns perfectly with our overall sustainability strategy and our specific objective of creating a positive local impact in the communities we serve.”

About Tata Memorial Centre
Tata Memorial Centre is a grant-in-aid institution under the Department of Atomic Energy, Government of India. Founded in 1941, it is one of the largest cancer centers in the world, providing exceptional clinical service, imparting high-quality training, and conducting innovative need-based clinical research. The hospital caters to over 70,000 new patients each year – among them 3,000 are children (less than 18 years of age). Patients come from all over the country and a vast majority (at least 70%) are given free or highly subsidized treatment. The Department of Pediatric Oncology endeavors to provide holistic support to all children with cancer, during their difficult journey of cancer treatment. https://tmc.gov.in/index.php/en/

About DKSH
DKSH’s purpose is to enrich people’s lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. With 53 innovation centers and regulatory support worldwide, DKSH creates cutting-edge formulations that comply with local regulations. With around 1,600 specialists, the Business Unit generated net sales of CHF 1.4 billion in 2023. www.dksh.com/pm

 

For further information, please contact: 
 
DKSH India Pvt. Ltd.  
Nitesh Lalla                                                            
Senior Manager, Facility Management         
Phone +91 99 8733 2929                                         
nitesh.lalla@dksh.com                                   

Olive Fernandes                                                            
Manager, Marketing & Communications         
Phone +91 98 1970 9478                                         
olive.fernandes@dksh.com      

Downloads

Select a market